Partner
Goodwin
Natalie Martirossian is a rising star in Goodwin’s Technology group, where she’s played a pivotal role in several of the firm’s recent market-altering M+A deals, venture financings and capital markets transactions. Martirossian has represented many clients for several years, and her philosophy is emblematic of the firm’s focus on building long-term relationships and providing guidance throughout the corporate life-cycle. Her varied practice includes pre-incorporation planning, general corporate representation and counseling, venture capital financings, mergers and acquisitions, public offerings, corporate governance, SEC compliance, and public company representation. She also works with venture capitalists in private stock offerings as well as investment banks in public stock offerings. Martirossian has served as a key figure on numerous recent matters, including advising Powered Brands on its upsized $240.0 million IPO; and advising MyoKardia, Inc. in its acquisition by Bristol Myers Squibb for $13.1 billion.
